Application no. and date | 07797634.8 (espacenet) (Federated) (European Patent Register), 20070522 | Patent/reg. no. and date | DK/EP 2028937, 20150128 | Publication date | 20090304 | Priority no. and date | US 747847 P, 20060522 | EP pub. no. and date |
EP 2028937 20090304 | Effective date | | Applicant/owner | Vanda Pharmaceuticals Inc., 2200 Pennsylvania Ave NW,
Suite 300-E
Washington, DC 20037, US | Applicant ref. no. | SH/GP/150468 | Inventor | POLYMEROPOULOS, Mihael, H., 11300 Ridge Mist Terrace
Potomac, MD 20854, US, BIRZNIEKS, Gunther, 6321 Tone Court
Bethesda, MD 20817, US, PHADKE, Deepak, 14313 West 123rd Street
Olathe, KS 66062, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/405 (2006.01) , A61P 43/00 (2006.01) | Title | Behandling med melatoninagonister | Int. application no. | US2007069411 | Int. publication no. | WO2007137244 | Related patent (certificate) | CA 2016 00009 | Status | Ændret DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|